“…The decrease in cells viability might be connected with a synergistic effect of ICR-191 and AgNP-MUA nanoparticles. AgNP-MUA has a described tendency to aggregate, which might lead to the increased toxicity, explained by clouding of the cell membranes, and thereby facilitates ICR-191 activity [23,24,41]. Many cells lines that interact with AgNPs have been cultured and studied so far, including red blood cells, L929 fibroblasts, RAW 264.7 murine macrophages, L5178Y lymphoma cells, BRL3A rat liver cells, PC-12 pheochromocytoma-derived cell neuroendocrine cells, GSCs germ line stem cells, RBE4 rat brain endothelial cells, MCF-7 human breast adenocarcinoma cells, HepG2 human liver cells, BEAS-2B human bronchial epithelial cells, A4549 lung alveolar epithelial cells, and hMSC (human mesenchymal stem cells).…”